CDIX.US Cardiff Lexington Corp

Healthcare Capital Markets USA Stocks
0.0050 USD
Close of Nov 13, 2026
0.0049 6.00
Market cap
USD 78.2K
P/E
-
P/B
-
ROE
-735.9%
Dividend yield
63.95%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CDIX.US undervalued?

Graham number

The Graham number of Cardiff Lexington Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cardiff Lexington Corp fundamental analysis

No fundamental analysis for Cardiff Lexington Corp yet.

Cardiff Lexington Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cardiff Lexington Corp

Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain proced…

Full company profile